PAL S. (2013) EVALUATION OF CYSTATIN C AS AN EARLY MARKER OF RENAL IMPAIRMENT IN DIABETIC AND HYPERLIPIDAEMIC PATIENTS. World Research Journal of Medical Science. 1(1). p. 13-17.